Creyos Health
Creyos Health is a scientifically validated, clinician-trusted, and patient-friendly platform that combines proprietary online tasks with digitized behavioral health questionnaires. Healthcare providers receive a complete, research-backed solution for detecting cognitive impairment and behavioral health conditions that is flexible, engaging, accurate, and reimbursable. The platform is backed by over 30 years of scientific research and has been used in more than 400 peer-reviewed studies. Over 10,000 healthcare providers trust Creyos in their practices to evaluate patient cognition and behavioral health. Creyos offers a suite of 12 online cognitive tasks, each taking only 2-3 minutes to complete, designed to detect even mild cognitive impairment. These tasks assess key domains such as short-term memory, reasoning, concentration, and verbal ability. The platform also includes digitized behavioral health screeners that automatically tabulate results, providing quick insights.
Learn more
Tridiuum
A digital behavioral health platform, Tridiuum ONE automates the identification of patient behavioral needs, accelerates access to the most appropriate care, and helps deliver better overall outcomes. Used by medical and behavioral health providers and health plans, Tridiuum ONE serves as a foundation for behavioral health evaluation and supports clinical decision making throughout the continuum of care.
Tridiuum ONE combines a digital behavioral health assessment with an advanced analytics engine to rapidly identify patient behavioral health issues, assign risk scores, and generate alerts which are delivered in real-time at the point of care. It also supports video-based virtual visits, enterprise-level dashboards into population statistics and clinician performance, and provider-level views into patient progress.
Learn more
MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
